Hong Kong Stock Exchange · ETF
Invest in 2820 ETF from India
Indian and foreign residents can buy Global X China Biotech ETF (2820) units directly through Paasa.
By Paasa · Updated
2820 at a glance
- Price
- HK$74.72+HK$0.00 (0.00%)
- Expense ratio
- 0.68%
- Day range
- HK$74.44 – HK$74.72
- Assets
- HK$693.6M
- Domicile
- Hong Kong
- Holdings
- 30
- Launched
- 2019
- Dividends
- —
- 1 month
- -0.61%
- 6 months
- +13.56%
- YTD
- +8.48%
- 1 year
- -6.58%
- 5 years
- -35.39%
Price change, excluding dividends.
Top 10 holdings
- 1WUXI BIOLOGICS CAYMAN INC2269.HK11.3%
- 2WUXI APPTEC603259.SS11.0%
- 3BEONE MEDICINES-ADRONC9.9%
- 4INNOVENT BIOLOGICS INC1801.HK9.2%
- 5JIANGSU HENGRUI PHARMACEUT600276.SS6.7%
- 6AKESO INC9926.HK5.7%
- 7SINO BIOPHARMACEUTICAL1177.HK4.4%
- 8GENSCRIPT BIOTECH CORP1548.HK3.8%
- 9HANSOH PHARMACEUTICAL GROUP3692.HK3.7%
- 10PHARMARON BEIJING300759.SZ3.2%
2820 holds 30 securities in total. These 10 are 68.8% of the fund.
Where the money is invested
Countries
- China59.5%
- Other29.5%
- Hong Kong9.6%
- Switzerland1.5%
How to invest in 2820 from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 2820 and buy
Find the fund by its ticker, 2820, on the Hong Kong Stock Exchange, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in 2820 from India
What 2820 holds
The Global X China Biotech ETF strives to achieve investment returns that closely mirror the performance of its designated benchmark index, prior to the subtraction of any fees and expenses.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy 2820 from India?
Yes. Indian residents can buy Global X China Biotech ETF (2820) through Paasa. It is listed on the Hong Kong Stock Exchange and trades in HKD. Your money leaves India under the RBI's Liberalised Remittance Scheme, and the units are held in your own name at Interactive Brokers.
What does 2820 invest in?
Global X China Biotech ETF holds 30 securities. Its largest holdings are WUXI BIOLOGICS CAYMAN INC (11.3%), WUXI APPTEC (11.0%) and BEONE MEDICINES-ADR (9.9%). The fund is domiciled in Hong Kong.
What is the expense ratio of 2820?
Global X China Biotech ETF has an expense ratio of 0.68% a year, taken from the fund's assets rather than billed to you. The fund manages about HK$693.6M.
What tax do I pay in India when I sell 2820?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation, and gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.
Can I buy a single 2820 unit?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$74.72 a unit, size the order by the lot.